| 3 min read
To help clinicians monitor slow-healing chronic wounds, researchers created the iCares device and tested it in 20 people with a variety of wounds.
| 4 min read
The understudied human gut bacteria P. faecium counteracted weight gain in mice by reducing inflammation, revealing a potential new way to treat obesity.
| 4 min read
Two new FDA approvals and promising clinical trial results for drugs to treat diabetes and lung cancer, and more led the news this week.News
| 5 min read
Cancer researchers predict how artificial intelligence and machine learning will impact oncology drug discovery, drug development, and diagnostics.
| 10+ min read
Using artificial intelligence and machine learning, a team of researchers engineered an enzyme to degrade toxic PFAS molecules — and they’re only in high school.
| 3 min read
Boosting UBA5 gene production normalized neuronal activity in the first organoid model of the developmental and epileptic encephalopathy.
| 3 min read
A blood test for organ rejection, another death related to gene therapy for Duchenne muscular dystrophy, a setback for AbbVie, and more led the news this week.
| 7 min read
To get drugs to reach the choroid and retina, ophthalmologists have relied on imperfect methods with drawbacks. Suprachoroidal delivery could be the fix.
| 4 min read
The drug, ubrogepant, mitigated many of the symptoms that precede the worst of a migraine and hinted at the condition’s origin.
| 3 min read
Clinical trials rigorously test treatments to further scientific knowledge and benefit patients. Neither happens if the results are never published.
| 4 min read
The Bethesda Declaration, a new RSV antibody for kids, amylin’s promising weight loss results, and more were industry’s need-to-know stories this week.
| 8 min read
With new insight into IgE biology, a new, two-pronged strategy for eliminating the pathogenic immune cells that lead to allergies emerges.
| 7 min read
People with hemophilia are hesitant to take the FDA-approved drugs for a variety of reasons, experts say. Pharma and biotech companies have taken notice.
| 5 min read
Via a unique regulatory route in the UK, scientists found that a gene therapy restored vision in young kids with a very rare and severe retinal dystrophy.
| 3 min read
By identifying high-risk pregnancies early, Mirvie’s new RNA-based test opens the door to timely prevention.
| 5 min read
Promising small cell lung cancer results, COVID-19 vaccine confusion, billion-dollar deals, and more led the news this week.
| 9 min read
Galimedix has recruited people with dry AMD to test the efficacy of their drug, which disrupts the same toxic beta-amyloid oligomers implicated in Alzheimer’s disease.
| 2 min read
Plummeting blood sugar can accelerate eye damage due to diabetes. Results in mice suggest that a new drug targeting hypoxia inducible factor could help.
| 6 min read
Rather than permanently cutting DNA, this new kind of gene therapy instead aims to regulate gene expression using epigenetic mechanisms.
| 4 min read
A novel immunotherapy targets the liver to promote tolerance to allergens in mice, promising durable allergy relief without the risk of severe reactions.
Page 1 of 31 - 610 Total Items
